13.40USD-0.22%Mkt Cap: 3.52B USDP/E: 14.41Last update: 2026-05-26
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, …
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap3.52B USD
Enterprise Value10.98B USD
Revenue (TTM)6.16B USD
Gross Profit3.31B USD
Net Income (TTM)187.00M USD
Revenue/Share23.69 USD
Last Price13.40 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)14.41
P/E (Forward)3.67
PEG—
EV/EBITDA6.88
EV/Revenue1.78
P/S0.57
P/B3.90
EPS (TTM)0.93
EPS (Forward)3.66
52W Range
5.69099% of range13.48
52W High13.48 USD
52W Low5.690 USD
Profitability
Gross Margin53.30%
Oper. Margin18.70%
EBITDA Margin25.88%
Profit Margin3.01%
ROE24.87%
ROA1.45%
Growth
Revenue Growth-3.50%
Earnings Growth66.70%
Cash Flow & Leverage
Operating CF700.00M USD
CapEx (TTM)316.00M USD
FCF Margin8.59%
FCF Yield15.03%
Net Debt7.45B USD
Net Debt/EBITDA4.67
Balance Sheet
Debt/Equity11.49
Current Ratio1.97
Quick Ratio1.00
Book Value/Sh3.438 USD
Cash/Share4.250 USD
Dividends
Fwd Div Rate0.0800 USD
Trail. Div Rate0.0800 USD
Div. Yield0.60%
5Y Avg Yield—
Payout Ratio8.60%
Ex-Div DateMay 11, 2026
Pay DateJun 11, 2026
Analyst Consensus
Rating3.2 (Hold)
Target (Mean)11.25 USD
Target Range8.000 USD – 14.00 USD
# Analysts4
Ownership
Shares Out.262.60M
Float261.08M
Insiders0.39%
Institutions77.85%
Short Interest
Short Ratio1.2d
Short % Float8.44%
Short % Out.7.42%
Shares Short19.49M
Short (prev mo.)22.13M
Technical
SMA 509.565 (+40.1%)
SMA 2008.700 (+54.0%)
Beta1.55
S&P 52W Chg28.31%
Avg Vol (30d)12.59M
Avg Vol (10d)4.23M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—